ArticleCell reports methods2025
A structural machine learning approach for rapid prediction of thermodynamically destabilizing tyrosine phosphorylations.
Article in Cell reports methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
Tyrosine phosphorylations are a prominent characteristic of numerous diseases, yet it is challenging to identify potentially (dys)functional phosphorylations among thousands of phospho-proteins. Here, we propose a machine learning method to predict the thermodynamic stability change resulting from tyrosine phosphorylation. Our approach, based on the prediction of phosphomimetic stability (ΔΔG) from structural features, strongly correlates with experimental phosphorylation stability and mutational scanning cDNA proteolysis data (R = 0.55-0.67). We apply our approach to predict the potential destabilizing effects of all 384,858 tyrosine residues from the Alphafold2 database, the PhosphoSitePlus database, and on a pan-cancer phosphoproteomics dataset with 11 cancer subtypes. We predict destabilizing phosphorylations in both oncogenes and tumor suppressors, and ΔΔG values and local protein circuit topology features are able to distinguish phospho-proteins that are known to be dysregulated in cancer. Our approach can enable rapid screening of destabilizing phosphorylations and phosphomimetic mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.